Clinical Trials Browser

Phase 3 × Interventional × Positron-Emission Tomography × Clear all

NCT04186845 2025-09-22

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Disease, Prostatic Neoplasms